Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects (NCT06854120)
Body Surface Gastric Mapping in Patients With Dyspeptic Symptoms: Recordings at Baseline and on Medical Therapy
🩺 Plain-English Summary (8th-Grade Level)
Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with gastric emptying tests, although the correlation with symptoms is weak. Prokinetic agents (e.g., metoclopramide, erythromycin) and symptom modulators (e.g., nortriptyline, mirtazapine) are commonly used, but selecting the right medication can be difficult, as it's often based on symptoms rather than the underlying gastric issues. Body Surface Gastric Mapping (BSGM) using the Gastric Alimetry device is a novel, non-invasive tool to assess gastric myoelectrical activity and symptoms. This study aims to perform two BSGM recordings-one before and one after medical therapy-to understand how medications affect gastric function and identify baseline BSGM factors that could predict responses to treatment, potentially guiding tailored therapies based on individual gastric dysfunction.
Who can join: Review the eligibility criteria below.
Location: Temple University — Philadelphia, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Temple University — Philadelphia, Pennsylvania
- Western Sydney University — Sydney, New South Wales
- Te Whatu Ora Waitemata — Auckland, Auckland
📞 Contact the Study Coordinator
Phone: (649) 373-7599
Email: gen.johnston@auckland.ac.nz
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gastroparesis
- Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve — Indianapolis, Indiana
- Vagus Nerve Response in Gastroparesis Patients — Indianapolis, Indiana
- ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve — Indianapolis, Indiana
- Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator — Dallas, Texas
- Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis — Indianapolis, Indiana
- Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial — Cleveland, Ohio
Explore by condition: All Gastroparesis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.